Related Experiment Video
Updated: Jul 14, 2026
09:33
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Tumor angiogenesis in gynecological oncology
A Mandić1, T Vujkov, P Novaković
1Department of Gynecologic Oncology, Institute of Oncology Sremska Kamenica, Novi Sad, Yugoslavia.
Summary
Tumor angiogenesis, the growth of new blood vessels fueling cancer, is crucial for tumor expansion and spread. High microvessel density indicates poor prognosis across many cancer types, guiding new anti-angiogenic therapies.
Area of Science:
- Oncology
- Cancer Research
- Vascular Biology
Background:
- Angiogenesis is essential for tumor growth and metastasis.
- Vascular endothelial growth factor (VEGF) is a key pro-angiogenic factor.
- Tumor angiogenesis is increasingly recognized as a significant prognostic factor in various cancers.
Purpose of the Study:
- To review the role of tumor angiogenesis in cancer progression.
- To highlight the importance of angiogenesis markers in prognosis and as potential tumor markers.
- To discuss the implications of anti-angiogenic strategies in cancer treatment.
Main Methods:
- Review of recent studies in gynecological oncology and other cancer types.
- Immunohistochemical analysis to assess microvessel density (MVD).
- Examination of the role of angiogenic growth factors, particularly VEGF.
Main Results:
- High MVD is associated with poor prognosis in cervical, endometrial, vulvar, and ovarian cancers.
- Tumor angiogenesis and related factors are important in breast, gastrointestinal, and soft-tissue sarcoma cancers.
- Angiogenic factors and MVD are not specific to a single tumor type.
Conclusions:
- Tumor angiogenesis plays a critical role in the natural history of cancer.
- Angiogenesis markers hold potential as prognostic factors.
- Anti-angiogenic therapies represent a promising frontier in oncology.
More Related Videos
Related Concept Videos
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...